VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.4948
-0.0052 (-1.04%)
At close: May 12, 2025, 4:00 PM
0.4948
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$14,512
Profits / Employee
-$317,269
Market Cap
47.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNRX News
- 16 hours ago - VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update - PRNewsWire
- 5 days ago - VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption - PRNewsWire
- 13 days ago - VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets - PRNewsWire
- 6 weeks ago - VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update - PRNewsWire
- 6 weeks ago - Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025 - PRNewsWire
- 6 weeks ago - Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025 - PRNewsWire
- 6 weeks ago - VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering - PRNewsWire